Hepatocellular carcinoma (HCC) has been increasing in incidence over the last several
decades. Previously limited to Eastern Asia, HCC has become increasingly prevalent in the …

Elimination of viral hepatitis in sub-Saharan Africa by 2030 is an ambitious feat. However, as
stated by the World Health Organization, there are unprecedented opportunities to act and …

Hepatocellular carcinoma (HCC) is a disease of global public health significance with
mortality on the rise, despite the preventable nature of its risk factors especially in Africa. It is …

Contamination of African staple foods is a major issue for human and animal health,
nutrition, and trade. This review aimed to collect and synthesize the available evidence on …

With the highest annual fatality ratio (mortality-to-incidence ratio), reported for a human
cancer, hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related …

Approximately 80 million people live with chronic hepatitis B virus (HBV) infection in the
WHO Africa Region. The natural history of HBV infection in this population is poorly …

Hepatitis B infection (HBV) is one of the most common causes of hepatocellular carcinoma
(HCC) worldwide. The age of occurrence, prognosis and incidence vary dramatically …

There is a clear and unmet need for biomarkers in hepatocellular carcinoma (HCC).
Circulating cell free deoxyribonucleic acid (cfDNA) is a fragmented DNA subtype, found in …

The face of primary liver cancer has evolved over the past century and is one of the most
commonly diagnosed cancers in the world. Despite advancements in screening and …

Hepatitis B virus (HBV) genotype E (HBV‐E) accounts for the majority of chronic hepatitis B
(CHB) infections in West Africa. We aimed to determine factors associated with HBV‐E …